Endometrial Cancer Trial, Recruiting (NCT05472311)

Endometrial Cancer Trial, Recruiting NCT05472311 Sponsor: University of Washington Condition: Endometrial Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05472311 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometrial Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a policy maker involved in healthcare decisions
You are a health facility manager
You are a healthcare provider working at one of the reproductive health clinics taking part in this study
You are a woman aged between 25 and 60 years old who is coming to a participating clinic for cervical cancer screening
You are a woman who has been told that her screening result showed a possible pre-cancerous change on the cervix
You are willing to give your consent to take part in the study

Who may not be able to join:

Anyone who does not wish to take part or does not want their information to be used for research purposes

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nelly Mugo, MPH, MMed, University of Washington

Phone: 206-520-3866

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05472311

Sponsor: University of Washington

Phase: Not Applicable

Status: Recruiting

Condition: Endometrial Cancer

Trial contact: 206-520-3866

More information: https://clinicaltrials.gov/study/NCT05472311

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a policy maker involved in healthcare decisions
You are a health facility manager
You are a healthcare provider working at one of the reproductive health clinics taking part in this study
You are a woman aged between 25 and 60 years old who is coming to a participating clinic for cervical cancer screening
You are a woman who has been told that her screening result showed a possible pre-cancerous change on the cervix
You are willing to give your consent to take part in the study

Who may not be able to join:

Anyone who does not wish to take part or does not want their information to be used for research purposes

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Washington

Registry

ClinicalTrials.gov

Start date

17 May 2022

Est. completion

26 April 2026

Where this trial is recruiting

Kenya

Primary endpoints

Index of barriers to introduction of SAT_SVA+TA; Index of facilitators to introduction of SAT_SVA+TA; Deliver and Using the RE-AIM Framework Evaluate the Implementation of Thermal Number of providers trained who continue to provide treatment for pre-cancer lesions of the cervix using thermal ablation with a single visit approach; Impact of the SVA-SAT+TA on effective uptake of treatment of pre-cancer lesions of the cervix; Sustained use of TA to treat pre cancer lesions of the cervix in RH clinics in Kenya; HPV Clearance post treatment with TA

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov